Business Information
The group's principal activities are to develop, manufacture, package, market and distribute pharmaceutical products. It also provides contract manufacturing and packaging services for pharmaceutical products for other companies. The group manufactures and sells a line of both prescription and over-the-counter drug products. As of 30-Jun-2003, it manufactured or distributed 23 products, all of which are either tablets, or capsules and sold generically to the drug distribution industry. They include fiorinal(R) , lanoxin(R), mysoline(R), bentyl(R), diamox(R), lomotil(R), and unithroid(R) . These are used in the treatment of migraine headaches, heart failure, epilepsy, glaucoma, diarrhea, tuberculosis, thyroid deficiency and allergies. The group sells its pharmaceutical products primarily to wholesalers, distributors, warehousing chains, retail chains and other pharmaceutical companies.
|
Name |
Title
|
Email
|
Bernard Sandiford | Pres. - Operations | N/A | Brian Kearns | VP - Finance, Treasurer, Sec., CFO | N/A | Kevin Smith | VP - Sales, Marketing | N/A | William Schreck | VP - Logistics | N/A | Albert Wertheimer | Dir. | N/A |
|
Year |
Sales |
Net Income |
2006 | 64,060 | 4,969 | 2005 | 44,902 | (32,780) | 2004 | 63,781 | 13,215
| |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
Click for more Executives |
|
|